SUBJECTS : Pharmacoeconomics | Public Health | Infectious Diseases | Epidemiolog
Infectious Diseases and Therapy: 2023, vol: , issue:
- 1)- George Kassianos, Osamah Barasheed, Victoria Abbing-Karahagopian, Mansour Khalaf, Serdar Ozturk, Angelika Banzhoff, Selim Badur. Correction to: Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review. Infectious diseases and therapy. 2023, 12 (9): 2221-2222
Cited : 0Read More - 2)- Mayan Gilboa, Nadav Baharav, Eyal Melzer, Gili Regev-Yochay, Dafna Yahav. Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review. Infectious diseases and therapy. 2023, 12 (9): 2223-2240Cited : 3Read More
- 3)- Louise Murdoch, Karen Quan, James A Baber, Agnes W Y Ho, Ying Zhang, Xia Xu, Claire Lu, David Cooper, Kenneth Koury, Stephen P Lockhart, Annaliesa S Anderson, Özlem Türeci, Uğur Şahin, Kena A Swanson, William C Gruber, Nicholas Kitchin, . Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults. Infectious diseases and therapy. 2023, 12 (9): 2241-2258Cited : 5Read More
- 4)- Laila Carolina Abu Esba, Ghada Al Mardawi, Elham Al Mardawi, Fay Musaed Almadhi, Husam I Ardah. Misoprostol-Induced Fever and Unnecessary Antibiotic Prescribing: A Retrospective Study. Infectious diseases and therapy. 2023, 12 (9): 2259-2268Cited : 0Read More
- 5)- F D Richard Hobbs, Hugh Montgomery, Francisco Padilla, Jesus Abraham Simón-Campos, Kenneth Kim, Douglas Arbetter, Kelly W Padilla, Venkatesh Pilla Reddy, Seth Seegobin, Katie Streicher, Alison Templeton, Rolando M Viani, Eva Johnsson, Gavin C K W Koh, Mark T Esser. Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial. Infectious diseases and therapy. 2023, 12 (9): 2269-2287Cited : 5Read More
- 6)- Michael Gemmell, Tyler Walsh, Michael Sherby, Adwoa Imbeah, Kelly Bono, Megan Baldenweck, Christina Gurnett, Jason G Newland. Clusters of SARS-CoV-2 Infection Across Six Schools for Students with Intellectual and Developmental Disabilities. Infectious diseases and therapy. 2023, 12 (9): 2289-2294Cited : 0Read More
- 7)- Ming M Zhang, Ryan W Stevens, Jennifer L Adema, Kristin C Mara, Audrey N Schuetz, Aaron J Tande, Christina G Rivera. A Pharmacovigilance Analysis of Daptomycin Use Based on CLSI Susceptible Dose-Dependent Category. Infectious diseases and therapy. 2023, 12 (9): 2295-2305Cited : 0Read More
- 8)- Caroline R Perry, Nicole E Scangarella-Oman, Helen Millns, William Flight, Sally Gatsi, Charles Jakielaszek, Salim Janmohamed, David A Lewis. Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study. Infectious diseases and therapy. 2023, 12 (9): 2307-2320Cited : 6Read More
- 9)- Judith A Aberg, Bronagh Shepherd, Marcia Wang, Jose V Madruga, Fernando Mendo Urbina, Christine Katlama, Shannon Schrader, Joseph J Eron, Princy N Kumar, Eduardo Sprinz, Margaret Gartland, Shiven Chabria, Andrew Clark, Amy Pierce, Max Lataillade, Allan R Tenorio. Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1. Infectious diseases and therapy. 2023, 12 (9): 2321-2335Cited : 4Read More
- 10)- Liana R Clark, David R Johnson. Safety and Clinical Benefits of Adacel and Adacel-Polio Vaccination in Pregnancy: A Structured Literature Review. Infectious diseases and therapy. 2023, 12 (8): 1955-2003Cited : 1Read More
- 11)- Jos Luttjeboer, Joost Simons, Tjalke Westra, Jan Wilschut, Cornelis Boersma, Maarten Postma, Jurjen van der Schans. An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands. Infectious diseases and therapy. 2023, 12 (8): 2135-2145Cited : 0Read More
- 12)- Davide Fiore Bavaro, Roberta Papagni, Alessandra Belati, Lucia Diella, Antonio De Luca, Gaetano Brindicci, Nicolò De Gennaro, Francesco Di Gennaro, Federica Romanelli, Stefania Stolfa, Luigi Ronga, Adriana Mosca, Francesco Pomarico, Maria Dell'Aera, Monica Stufano, Lidia Dalfino, Salvatore Grasso, Annalisa Saracino. Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study. Infectious diseases and therapy. 2023, 12 (8): 2147-2163Cited : 10Read More
- 13)- Jing Lin, Li Zhang, Menglan Zhou, Xiaotong Tian, Jialong Chen, Minya Lu, Zhengyin Liu. Combination Therapy of Ceftazidime/Avibactam for the Treatment of Patients Infected with Carbapenem-Resistant Klebsiella pneumoniae: A Multicenter Retrospective Study. Infectious diseases and therapy. 2023, 12 (8): 2165-2177Cited : 1Read More
- 14)- Motoyuki Sugai, Akira Yuasa, Ryan L Miller, Vasileios Vasilopoulos, Hitomi Kurosu, Amer Taie, Jason P Gordon, Tetsuya Matsumoto. Correction to: An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan. Infectious diseases and therapy. 2023, 12 (8): 2191-2192Cited : 0Read More
- 15)- Camila G Freitas, Maria Sueli Felipe. Candida albicans and Antifungal Peptides. Infectious diseases and therapy. 2023, 12 (12): 2631-2648Cited : 4Read More
- 16)- David E Bloom, Paolo Bonanni, Federico Martinón-Torres, Peter C Richmond, Marco A P Safadi, David M Salisbury, Apostolos Charos, Katharina Schley, Jamie Findlow, Paul Balmer. Meningococcal Disease in the Post-COVID-19 Era: A Time to Prepare. Infectious diseases and therapy. 2023, 12 (12): 2649-2663Cited : 2Read More
- 17)- Fuzhen Zhang, Fan Zhang, Yu Dong, Liang Li, Yu Pang. New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative Review. Infectious diseases and therapy. 2023, 12 (12): 2665-2689Cited : 5Read More
- 18)- Gustavo H Kijak, Bahar Ahani, Douglas Arbetter, Fernando Chuecos, Vancheswaran Gopalakrishnan, Jagadish Beloor, Tyler Brady, Amy Nguyen, Tiffany L Roe, Nicolette Schuko, Tianhui Zhang, F D Richard Hobbs, Francisco Padilla, Elizabeth J Kelly, Hugh Montgomery, Katie Streicher. Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial). Infectious diseases and therapy. 2023, 12 (12): 2691-2707Cited : 1Read More
- 19)- Wilfrido Coronell-Rodriguez, Diana C Caceres, Otavio Cintra, Adriana Guzman-Holst. Epidemiology of Invasive Meningococcal Disease in Colombia: A Retrospective Surveillance Database Analysis. Infectious diseases and therapy. 2023, 12 (12): 2709-2724Cited : 0Read More
- 20)- Julie M Strizki, Jay A Grobler, Nicholas Murgolo, Arthur Fridman, Matthew G Johnson, Jiejun Du, Patricia Carmelitano, Michelle L Brown, Amanda Paschke, Carisa De Anda. Virologic Outcomes with Molnupiravir in Non-hospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial. Infectious diseases and therapy. 2023, 12 (12): 2725-2743Cited : 1Read More
- 21)- Taito Kitano, Shinya Tsuzuki, Ryuji Koizumi, Kensuke Aoyagi, Yusuke Asai, Yoshiki Kusama, Norio Ohmagari. Factors Associated with Geographical Variability of Antimicrobial Use in Japan. Infectious diseases and therapy. 2023, 12 (12): 2745-2755Cited : 0Read More
- 22)- Siyue Jia, Jinlong Zhang, Xue Wang, Zhe Zhang, Busen Wang, Jun Zhang, Hudachuan Jiang, Ge Guo, Ying Wang, Jingxuan Wan, Wenjuan Wang, Lihua Hou, Fengcai Zhu. Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18-60 Years: a Single-Center, Open-Label Trial. Infectious diseases and therapy. 2023, 12 (12): 2757-2769Cited : 1Read More
- 23)- Jing Chen, Ju-Young Shin, Sumitra Shantakumar, Sungho Bea, Byong Duk Ye, Dong-Gun Lee, Hyungwoo Kim, Won Suk Choi, Iain Kaan. Burden of Herpes Zoster in Individuals with Immunocompromised Conditions and Autoimmune Diseases in the Republic of Korea: A Nationwide Population-Based Database Study. Infectious diseases and therapy. 2023, 12 (12): 2771-2790Cited : 1Read More
- 24)- Adriana Guzman-Holst, Jorge A Gomez, Otavio Cintra, Desirée Van Oorschot, Nicolas Jamet, Javier Nieto-Guevara. Assessing the Underestimation of Adult Pertussis Disease in Five Latin American Countries. Infectious diseases and therapy. 2023, 12 (12): 2791-2806Cited : 2Read More
- 25)- Michael G Sension, Laurence Brunet, Ricky K Hsu, Jennifer S Fusco, Quateka Cochran, Christine Uranaka, Gayathri Sridhar, Vani Vannappagari, Jean Van Wyk, Lewis McCurdy, Michael B Wohlfeiler, Gregory P Fusco. Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort. Infectious diseases and therapy. 2023, 12 (12): 2807-2817Cited : 10Read More
- 26)- Juan Ambrosioni, Marta Hernández-Meneses, Emanuele Durante-Mangoni, Pierre Tattevin, Lars Olaison, Tomas Freiberger, John Hurley, Margaret M Hannan, Vivian Chu, Bruno Hoen, Asunción Moreno, Guillermo Cuervo, Jaume Llopis, José M Miró, . Correction: Epidemiological Changes and Improvement in Outcomes of Infective Endocarditis in Europe in the Twenty-First Century: An International Collaboration on Endocarditis (ICE) Prospective Cohort Study (2000-2012). Infectious diseases and therapy. 2023, 12 (12): 2819-2821Cited : 1Read More
- 27)- Tamer Pehlivan, Ener Cagri Dinleyici, Ateş Kara, Zafer Kurugöl, Hasan Tezer, Nur Baran Aksakal, Aydan Biri, Alpay Azap. The Present and Future Aspects of Life-Long Pertussis Prevention: Narrative Review with Regional Perspectives for Türkiye. Infectious diseases and therapy. 2023, 12 (11): 2495-2512Cited : 2Read More
- 28)- Iain A Gillespie, Eleanor Barnes, Ian C K Wong, Philippa C Matthews, Graham S Cooke, Craig Tipple, Robert C Elston, Yunhao Liu, David A Smith, Tingyan Wang, Jim Davies, Kinga A Várnai, Oliver Freeman, Kenneth K C Man, Wallis C Y Lau, Ben Glampson, Xing Meng, Eleonora Morais, Sen Liu, Luca Mercuri, Naomi Boxall, Sarah Jenner, Stuart Kendrick, Jane Dong, Dickens Theodore. Correction to: Patient Biochemistry and Treatment Need in Chronic Hepatitis B Virus Infection Across Three Continents: Retrospective Cross-Sectional Cohort Studies. Infectious diseases and therapy. 2023, 12 (11): 2533-2534Cited : 0Read More
- 29)- Jiayu Wen, Jian-Qing He. The Causal Impact of the Gut Microbiota on Respiratory Tuberculosis Susceptibility. Infectious diseases and therapy. 2023, 12 (11): 2535-2544Cited : 0Read More
- 30)- Ewa Wardal, Dorota Żabicka, Tomasz Skalski, Joanna Kubiak-Pulkowska, Waleria Hryniewicz, Ewa Sadowy. Characterization of a Tigecycline-, Linezolid- and Vancomycin-Resistant Clinical Enteroccoccus faecium Isolate, Carrying vanA and vanB Genes. Infectious diseases and therapy. 2023, 12 (11): 2545-2565Cited : 2Read More
- 31)- Biying Wang, Wanjing Lin, Chen Qian, Youyi Zhang, Genming Zhao, Weibing Wang, Tao Zhang. Disease Burden of Meningitis Caused by Streptococcus pneumoniae Among Under-Fives in China: A Systematic Review and Meta-analysis. Infectious diseases and therapy. 2023, 12 (11): 2567-2580Cited : 0Read More
- 32)- Lin Gan, Xiaoxin Xie, Yanhua Fu, Xiaoyan Yang, Shujing Ma, Linghong Kong, Chunli Song, Yebing Song, Tingting Ren, Hai Long. Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study. Infectious diseases and therapy. 2023, 12 (11): 2581-2593Cited : 3Read More
- 33)- Rui Hua, Fei Kong, Guangming Li, Xiaofeng Wen, Yuexin Zhang, Xingxiang Yang, Chenxin Meng, Wen Xie, Yongfang Jiang, Xiaozhong Wang, Xueji Han, Yan Huang, Qing Mao, Jiefei Wang, Yujuan Guan, Jiayu Chen, Yingjie Ma, Qingfang Xiong, Hong Ma, Xuebing Yan, Huiying Rao, Yingren Zhao, Tong Sun, Liying Zhu, Xiaorong Mao, Jianqi Lian, Guojiong Deng, Yongning Xin, Yifei Wang, Yinong Ye, Bin Xu, Hainv Gao, Youwen Tan, Dongliang Li, Dongliang Yang, Minghua Su, Xiaomeng Zhang, Jie Min, Xinsheng Shi, Lai Wei,. Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China. Infectious diseases and therapy. 2023, 12 (11): 2595-2609Cited : 1Read More
- 34)- Hui Ye, Fei-Fei Su, Xiao-Ya Cui, Xiu-Xiu Guo, Tian-Ye Zhu, De-Yong Kong, Xing-Guo Miao. Evaluation of Different Blood Culture Bottles for the Diagnosis of Bloodstream Infections in Patients with HIV. Infectious diseases and therapy. 2023, 12 (11): 2611-2620Cited : 0Read More
- 35)- Juan Camacho, Anabel Negredo, Bartolomé Carrilero, Manuel Segovia, Antonio Moreno, Francisco Pozo, Juan-Emilio Echevarría, José-Manuel Echevarría, M Paz Sánchez-Seco, David Tarragó. Mutations in Coding and Non-Coding Regions in Varicella-Zoster Virus Causing Fatal Hemorrhagic Fever Without Rash in an Immunocompetent Patient: Case Report. Infectious diseases and therapy. 2023, 12 (11): 2621-2630Cited : 3Read More
- 36)- Isabelle Bertrand-Gerentes, Laurent Fanchon, Florence Coste, Richard E Glover, Tamazoust Guiddir, Muhamed-Kheir Taha. Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review. Infectious diseases and therapy. 2023, 12 (10): 2337-2351Cited : 0Read More
- 37)- Qi Wang, Jia Qiu, Jie-Leng Huang, Mei Jiang, Jun-Quan Lu, Di Wu, Xue-Biao Wei, Dan-Qing Yu. Prognostic Value of Blood Urea Nitrogen for Short-Term Mortality in Patients with Infective Endocarditis. Infectious diseases and therapy. 2023, 12 (10): 2353-2366Cited : 0Read More
- 38)- David Neveu, Tamala Mallett Moore, Betzana Zambrano, Aiying Chen, Marie-Laure Kürzinger, Lydie Marcelon, Mandeep Singh Dhingra. Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older. Infectious diseases and therapy. 2023, 12 (10): 2367-2386Cited : 1Read More
- 39)- Yuri Cho, SeongBeom Park, SeonYoung Park, WonJung Choi, Book Kim, Helin Han. Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea. Infectious diseases and therapy. 2023, 12 (10): 2387-2403Cited : 1Read More
- 40)- Ting Zeng, Kailu Wang, Zihao Guo, Shengzhi Sun, Ziyu Zhai, Yaoqin Lu, Zhidong Teng, Daihai He, Kai Wang, Maozai Tian, Shi Zhao. Distinguishing the Vaccine Effectiveness of Inactivated BBIBP-CorV Vaccine Booster Against the Susceptibility, Infectiousness, and Transmission of Omicron Stains: A Retrospective Cohort Study in Urumqi, China. Infectious diseases and therapy. 2023, 12 (10): 2405-2416Cited : 0Read More
- 41)- Ji Yeon Lee, Seon Hee Bu, EunHyang Song, Seongcheol Cho, Sungbong Yu, Jungok Kim, Sungmin Kym, Kwang Won Seo, Ki Tae Kwon, Jin Yong Kim, Sunghyun Kim, Keumyoung Ahn, Nahyun Jung, Yeonmi Lee, Yoobin Jung, Chankyoung Hwang, Sang Won Park. Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea. Infectious diseases and therapy. 2023, 12 (10): 2417-2435Cited : 0Read More
- 42)- Lorenzo Piemonti, Giovanni Landoni, Antonio Voza, Massimo Puoti, Ivan Gentile, Nicola Coppola, Stefano Nava, Alessia Mattei, Franco Marinangeli, Giulia Marchetti, Paolo Bonfanti, Claudio Maria Mastroianni, Matteo Bassetti, Ernesto Crisafulli, Paolo Antonio Grossi, Alberto Zangrillo, Antonio Desai, Marco Merli, Maria Foggia, Marco Carpano, Lorenzo Schiavoni, Antonella D'Arminio Monforte, Luca Bisi, Gianluca Russo, Fabiana Busti, Cristina Rovelli, Elisabetta Perrotta, Giovanni Goisis, Elizabeth M . Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study. Infectious diseases and therapy. 2023, 12 (10): 2437-2456Cited : 2Read More
- 43)- Xiaoxin Xie, Lin Gan, Yanhua Fu, Yebing Song, Chunli Song, Tingting Ren, Chan Ke, Hai Long. Pharmacokinetics and Safety of Ainuovirine/Lamivudine/Tenofovir Combination Tablets in Young and Elderly Patients with Human Immunodeficiency Virus-1 Infection. Infectious diseases and therapy. 2023, 12 (10): 2457-2469Cited : 0Read More
- 44)- Emiel Leegwater, Lisa Dol, Menno R Benard, Eveline E Roelofsen, Nathalie M Delfos, Machteld van der Feltz, Femke P N Mollema, Liesbeth B E Bosma, Loes E Visser, Thomas H Ottens, Nathalie D van Burgel, Sesmu M Arbous, Lahssan H El Bouazzaoui, Rachel Knevel, Rolf H H Groenwold, Mark G J de Boer, Leo G Visser, Frits R Rosendaal, Erik B Wilms, Cees van Nieuwkoop. Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study. Infectious diseases and therapy. 2023, 12 (10): 2471-2484Cited : 0Read More
- 45)- Razieh Kebriaei, Jacinda C Abdul-Mutakabbir, Kyle C Stamper, Katherine L Lev, Michael J Rybak. Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin. Infectious diseases and therapy. 2023, 12 (10): 2485-2494Cited : 0Read More
- 46)- Hiral Anil Shah, Anne Meiwald, Chamath Perera, Giacomo Casabona, Peter Richmond, Nicolas Jamet. Global Prevalence of Varicella-Associated Complications: A Systematic Review and Meta-Analysis. Infectious diseases and therapy. 2023, : Cited : 4Read More
- 47)- Stefania Maggi, Melissa K Andrew, Annemarijn de Boer. Podcast: Influenza-Associated Complications and the Impact of Vaccination on Public Health. Infectious diseases and therapy. 2023, : Cited : 0Read More
- 48)- Beatriz Arns, Jaqueline Driemeyer C Horvath, Gabriela Soares Rech, Guilhermo Prates Sesin, Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa, Tiago Marcon Dos Santos, Liliane Spencer Bittencourt Brochier, Alexandre Biasi Cavalcanti, Bruno Martins Tomazini, Adriano Jose Pereira, Viviane Cordeiro Veiga, Giovana Marssola Nascimento, Andre C Kalil, Alexandre P Zavascki. A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol. Infectious diseases and therapy. 2023, : Cited : 1Read More
- 49)- Chris Wynne, Abundio Balgos, Jingxin Li, Paul Hamilton, Louie Tirador, Anjuli May Jaen, Chen Mo, Zijing Yue, Ying Ma, Qingshuang Wang, Rendu Wen, Zheng Yao, Jiaping Yu, Wenrong Yao, Jianhui Zhang, Hui Zheng, Kunxue Hong, Fengcai Zhu, Yong Liu. Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies. Infectious diseases and therapy. 2023, : Cited : 0Read More
- 50)- Konstantina Iliopoulou, Panagiotis Koufargyris, Sarantia Doulou, Elisavet Tasouli, Sokratis Katopodis, Stavroula-Porphyria Chachali, Georgios Schinas, Charalampos Karachalios, Myrto Astriti, Paraskevi Katsaounou, George Chrysos, Theodoros Seferlis, Effrosyni Dimopoulou, Myrto Kollia, Garyphalia Poulakou, Styliani Gerakari, Ilias C Papanikolaou, Haralampos Milionis, George N Dalekos, Vasiliki Tzavara, Theano Kontopoulou, Evangelos J Giamarellos-Bourboulis. Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein. Infectious diseases and therapy. 2023, : Cited : 2Read More
